Literature DB >> 20180135

Urinary proteome analysis identifies infants but not older children requiring pyeloplasty.

Jens Drube1, Petra Zürbig, Eric Schiffer, Esther Lau, Benno Ure, Sylvia Glüer, Martin Kirschstein, Lars Pape, Stéphane Decramer, Jean-Loup Bascands, Joost P Schanstra, Harald Mischak, Jochen H H Ehrich.   

Abstract

One out of every five children suffering from ureteropelvic junction obstruction (UPJO) requires pyeloplasty. This prevalence indicates an urgent necessity to identify high-grade UPJO as early as possible to avoid renal damage. A novel non-invasive proteomic urine test has recently been introduced that is able to detect these patients at an early stage. In the study reported here, we tested this approach to assess its use in our centre and to expand its application to older children. Twenty-seven children (median age 0.4 years, range 0.1-8.8 years) with hydronephrosis who had been scheduled a nuclear diuretic renal scan (DR) to identify urodynamically relevant UPJO were included in our prospective study. Patients with prior surgery of the urinary tract were excluded. The urinary proteome pattern was analysed using capillary electrophoresis coupled to mass spectrometry. Of the 27 children, 11 had a relevant UPJO diagnosed by the DR. In 19 children <1 year of age, urinary proteome analysis predicted obstruction with a sensitivity of 83% (5/6) and a specificity of 92% (12/13). However, in older patients, the sensitivity decreased to 20% (1/5) and specificity to 66% (2/3). Based on our results, the proteome pattern established by Decramer and co-workers predicts the need for surgery in infants but not in older children with UPJO.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20180135     DOI: 10.1007/s00467-010-1455-8

Source DB:  PubMed          Journal:  Pediatr Nephrol        ISSN: 0931-041X            Impact factor:   3.714


  19 in total

Review 1.  Congenital urinary tract obstruction: Proceedings of the State-Of-The-Art Strategic Planning Workshop-National Institutes of Health, Bethesda, Maryland, USA, 11-12 March 2002.

Authors:  Robert L Chevalier; Craig A Peters
Journal:  Pediatr Nephrol       Date:  2003-04-26       Impact factor: 3.714

Review 2.  Upper urinary tract: when is obstruction obstruction?

Authors:  Dagmar Csaicsich; Larry A Greenbaum; Christoph Aufricht
Journal:  Curr Opin Urol       Date:  2004-07       Impact factor: 2.309

3.  Elevated bladder urine concentration of transforming growth factor-beta1 correlates with upper urinary tract obstruction in children.

Authors:  P D Furness; M Maizels; S W Han; R A Cohn; E Y Cheng
Journal:  J Urol       Date:  1999-09       Impact factor: 7.450

Review 4.  Congenital unilateral hydronephrosis: a review of the impact of diuretic renography on clinical treatment.

Authors:  Anni Eskild-Jensen; Isky Gordon; Amy Piepsz; Jørgen Frøkiaer
Journal:  J Urol       Date:  2005-05       Impact factor: 7.450

5.  Diuresis renal scintigraphy "F-0" in diagnosing of upper urinary tract obstruction in children: the clinical significance.

Authors:  Marina Vlajković; Slobodan Ilić; Milena Rajić; Vesna Petronijević; Tanja Bubanj; Vera Artiko
Journal:  Nucl Med Rev Cent East Eur       Date:  2005

6.  Ureteropelvic junction obstruction.

Authors:  John S Lam; Alberto Breda; Peter G Schulam
Journal:  J Urol       Date:  2007-05       Impact factor: 7.450

7.  MCP-1 and EGF renal expression and urine excretion in human congenital obstructive nephropathy.

Authors:  G Grandaliano; L Gesualdo; F Bartoli; E Ranieri; R Monno; A Leggio; G Paradies; E Caldarulo; B Infante; F P Schena
Journal:  Kidney Int       Date:  2000-07       Impact factor: 10.612

8.  Prediction of recovery in antenatally diagnosed hydronephrosis.

Authors:  K J O'Flynn; D C Gough; S Gupta; M A Lewis; R J Postlethwaite
Journal:  Br J Urol       Date:  1993-04

9.  Operative versus nonoperative management of ureteropelvic junction obstruction in children.

Authors:  Jonathan E Heinlen; C Scott Manatt; Brianna C Bright; Bradley P Kropp; Jeffrey B Campbell; Dominic Frimberger
Journal:  Urology       Date:  2008-12-18       Impact factor: 2.649

10.  Predicting the clinical outcome of congenital unilateral ureteropelvic junction obstruction in newborn by urinary proteome analysis.

Authors:  Stephane Decramer; Stefan Wittke; Harald Mischak; Petra Zürbig; Michael Walden; François Bouissou; Jean-Loup Bascands; Joost P Schanstra
Journal:  Nat Med       Date:  2006-03-19       Impact factor: 53.440

View more
  17 in total

Review 1.  Urinary biomarkers for renal tract malformations.

Authors:  Pedro Magalhães; Joost P Schanstra; Emma Carrick; Harald Mischak; Petra Zürbig
Journal:  Expert Rev Proteomics       Date:  2016-11-15       Impact factor: 3.940

2.  A single-center study to evaluate the efficacy of a fetal urine peptide signature predicting postnatal renal outcome in fetuses with posterior urethral valves.

Authors:  Bénédicte Buffin-Meyer; Marcin Tkaczyk; Małgorzata Stańczyk; Benjamin Breuil; Justyna Siwy; Krzysztof Szaflik; Tomasz Talar; Justyna Wojtera; Waldemar Krzeszowski; Stéphane Decramer; Julie Klein; Joost P Schanstra
Journal:  Pediatr Nephrol       Date:  2019-11-07       Impact factor: 3.714

Review 3.  Proteomic urinary biomarker approach in renal disease: from discovery to implementation.

Authors:  Joost P Schanstra; Harald Mischak
Journal:  Pediatr Nephrol       Date:  2014-03-15       Impact factor: 3.714

Review 4.  Urinary proteomics using capillary electrophoresis coupled to mass spectrometry for diagnosis and prognosis in kidney diseases.

Authors:  Pedro Magalhães; Harald Mischak; Petra Zürbig
Journal:  Curr Opin Nephrol Hypertens       Date:  2016-11       Impact factor: 2.894

5.  A novel urinary biomarker protein panel to identify children with ureteropelvic junction obstruction - A pilot study.

Authors:  Charan Kumar V Devarakonda; Emily R Shearier; Chaoran Hu; James Grady; Jeremy L Balsbaugh; John H Makari; Fernando A Ferrer; Linda H Shapiro
Journal:  J Pediatr Urol       Date:  2020-06-11       Impact factor: 1.830

6.  Urinary NGAL levels correlate with differential renal function in patients with ureteropelvic junction obstruction undergoing pyeloplasty.

Authors:  Nicholas G Cost; Paul H Noh; Prasad Devarajan; Vesna Ivancic; Pramod P Reddy; Eugene Minevich; Michael Bennett; Christopher Haffner; Marion Schulte; W Robert DeFoor
Journal:  J Urol       Date:  2013-06-20       Impact factor: 7.450

Review 7.  [Urinary proteomics: the diagnostic key for urinary tract abnormalities and kidney diseases in children?].

Authors:  J H H Ehrich; E Schiffer; J Drube
Journal:  Urologe A       Date:  2011-02       Impact factor: 0.639

8.  Urinary proteome analysis and the management of ureteropelvic junction obstruction.

Authors:  Hrair-George O Mesrobian
Journal:  Pediatr Nephrol       Date:  2010-04-21       Impact factor: 3.714

9.  Urinary levels of TGF β-1 and of cytokines in patients with prenatally detected nephrouropathies.

Authors:  Mariana A Vasconcelos; Maria Candida F Bouzada; Katia D Silveira; Leticia R Moura; Fabiana F Santos; Juliana M Oliveira; Flavia F Carvalho; Mauro M Teixeira; Ana Cristina Simões E Silva; Eduardo A Oliveira
Journal:  Pediatr Nephrol       Date:  2011-02-18       Impact factor: 3.714

10.  Label-free quantitative urinary proteomics identifies the arginase pathway as a new player in congenital obstructive nephropathy.

Authors:  Chrystelle Lacroix; Cécile Caubet; Anne Gonzalez-de-Peredo; Benjamin Breuil; David Bouyssié; Alexandre Stella; Luc Garrigues; Caroline Le Gall; Anthony Raevel; Angelique Massoubre; Julie Klein; Stéphane Decramer; Frédérique Sabourdy; Flavio Bandin; Odile Burlet-Schiltz; Bernard Monsarrat; Joost-Peter Schanstra; Jean-Loup Bascands
Journal:  Mol Cell Proteomics       Date:  2014-09-09       Impact factor: 5.911

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.